Atlas Trials

Endothelial Dysfunction and Subclinical Atheromatosis in Chronic HCV Infection. Response to DAA Agents.

Clinical trial NCT02802280 · UNKNOWN

Trial details

NCT number
NCT02802280
Sponsor
Instituto de Investigación Marqués de Valdecilla
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis CCardiovascular Diseases
Start date
2015-10-01
Primary completion
2016-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.